S180: RG6234, A NOVEL GPRC5D T-CELL ENGAGING BISPECIFIC ANTIBODY, INDUCES RAPID RESPONSES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: PRELIMINARY RESULTS FROM A FIRST-IN-HUMAN TRIAL. (23rd June 2022)

• Record Type: Journal Article
• Authors: Hasselbalch Riley, C.; Hutchings, M.; Yoon, S.-S.; Koh, Y.; Manier, S.; Facon, T.; Harrison, S. J.; Er, J.; Volzone, F.; Pinto, A.; Montes, C.; Ocio, E. M.; Alfonso-Pierola, A.; Rodriguez Otero, P.; Offner, F.; Guidetti, A.; Corradini, P.; Titouan, C.; Hulin, C.; Touzeau, C.; Moreau, P.; Popat, R.; Leong, S.; Mazza, R.; Bröske, A.-M. E.; Dekhtiarenko, I.; Helms, H.-J.; Belli, S.; Vardar, T.; Fauti, T.; Eckmann, J.; Moore, T.; Schneider, M.; Jacob, W.; Weisser, M.; Carlo-Stella, C.;
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 81
• Page End: 82
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000843612.41180.42
• Languages: English
• ISSNs: 2572-9241